False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients

Conclusions: Clinicians should be aware of potential technical issues in detecting AQP4-Ab in NTZ-treated patients leading to false positive results.

http://msj.sagepub.com/cgi/content/abstract/22/9/1231?rss=1

Source: Multiple Sclerosis - July 25, 2016 Category: Neurology Authors: Cohen, M., De Seze, J., Marignier, R., Lebrun, C. Tags: Case Reports Source Type: research

More News: Multiple Sclerosis | Neurology | Tysabri